Paid Clinical Trials in Doral, FL
As of June 2026, 87 paid clinical trials are recruiting in Doral, Florida. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Doral offers studies at sites including UM Sylvester Comprehensive Cancer Center at Doral for conditions such as Psychosis Associated With Alzheimer's Disease, Atopic Dermatitis, Alopecia Areata, Alzheimer Disease. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Doral
Filter results
0 clinical trials
·Clear filters·↓ Download CSVAbout research studies in Doral
Doral has approximately 87 recruiting research studies across a wide range of therapeutic areas. Florida hosts major research centers including Mayo Clinic Jacksonville, Moffitt Cancer Center, University of Miami Health System, and Nicklaus Children's Hospital, with strong programs in oncology and cardiovascular research.
Top Research Study Locations in Doral
Researchers run research studies in Doral, FL at 46 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| UM Sylvester Comprehensive Cancer Center at Doral | Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Metastatic Lung Non-Small Cell Carcinoma | 18 |
| St. Jude Clinical Research | Atopic Dermatitis, Bipolar I Disorder, Dermatitis Atopic | 5 |
| Universal Axon Clinical Research | Cardiovascular Diseases, Diabetes Mellitus, Type 2, Hypertension | 4 |
| AMR Clinical | Asthma, Metabolic Dysfunction-Associated Steatotic Liver Disease, Obesity | 3 |
| Dolphin Medical Research | Efficacy, Anemia, Helicobacter Pylori | 3 |
| GSK Investigational Site | Pulmonary Disease, Chronic Obstructive, Non-alcoholic Fatty Liver Disease | 3 |
| Sylvester Comprehensive Cancer Center- Doral | Multiple Myeloma, Breast Cancer, Breast Neoplasms | 3 |
| Akero Clinical Study Site | MASH - Metabolic Dysfunction-Associated Steatohepatitis, MASH With Fibrosis, NASH - Nonalcoholic Steatohepatitis | 2 |
| D&H Doral Research Center | Alopecia Areata, Diabetic Kidney Disease (DKD) | 2 |
| Integrity Clinical Research LLC - 21st Street | Alzheimer Disease, Psychosis Associated With Alzheimer's Disease | 2 |
| Prohealth Research Center | Irritable Bowel Syndrome With Constipation (IBS-C) | 2 |
| Altimmune Clinical Study Site | Alcohol Liver Disease | 1 |
| ADARx Clinical Site | C3G, Complement-mediated Kidney Disease, IC-MPGN | 1 |
| AMR-Miami | Diabetic Peripheral Neuropathic Pain | 1 |
| Bausch | Psoriasis | 1 |
| Baxis | Bacterial Conjunctivitis | 1 |
| Betancourt Research Services | Psychosis Associated With Alzheimer's Disease | 1 |
| BioResearch Partner ? Jackson West | Primary IgA Nephropathy | 1 |
| Bioresearch Partner | Central Line Associated Blood Stream Infections (CLABSI) | 1 |
| D&H Doral Research Center LLC | Alopecia, Areata Alopecia, Hair Diseases | 1 |
| D&H Doral Research Center, LLC | Chronic Obstructive Pulmonary Disease | 1 |
| D&H Doral Research Center-Doral | Bipolar I Disorder, Depression | 1 |
| DM Clinical Research - MIA | HOMA-IR, Mobility Disability, Obesity & Overweight | 1 |
| Dr. Falk Investigational Site | Eosinophilic Esophagitis | 1 |
| First Excellent Research Group | Alzheimer's Disease Psychosis | 1 |
| I.V.A.M. Clinical & Investigational Center, LLC | Ulcerative Colitis, Ulcerative Colitis Chronic | 1 |
| ICR Sites East | Gout | 1 |
| Innova Pharma Research | Idiopathic Pulmonary Fibrosis (IPF) | 1 |
| J&A Clinical Research | Moderately to Severely Active Crohns Disease | 1 |
| Local Institution - 1045 | Psychosis Associated With Alzheimer's Disease | 1 |
| Local Institution - 1164 | Psychosis Associated With Alzheimer's Disease | 1 |
| Local Institution - 2636 | Alzheimer Disease | 1 |
| MBX Biosciences Investigational Site | Obesity | 1 |
| Neurocrine Clinical Site | Schizophrenia | 1 |
| Omnicure Clinical Research | Chronic Spontaneous Urticaria (CSU) | 1 |
| Research | Urinary Tract Infections | 1 |
| Research | Severe Asthma | 1 |
| Revival Research | Atopic Dermatitis | 1 |
| Revival Research - Doral | Atopic Dermatitis | 1 |
| Revival Research | Alopecia Areata | 1 |
| St.Jude Clinical Research | Arthritis, Rheumatoid | 1 |
| Suncoast Research Associates, LLC | Heart Failure | 1 |
| UHC Research | Depressive Disorder, Major | 1 |
| Universal Axon Clinical Research (Rovia - UACR) | HOMA-IR, Mobility Disability, Obesity & Overweight | 1 |
| Universal Axon Clinical Research, LLC | COVID-19 SARS-CoV-2 Infection | 1 |
| Vanda Investigative Site | Hypertension, Uncontrolled Hypertension | 1 |
Active & Upcoming Studies in Doral (2026)
Recruiting trials in Doral grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (21 active studies)
- Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer · Phase 3 · National Cancer Institute (NCI)
- Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study · Phase 3 · NRG Oncology
Diabetes & metabolic (8 active studies)
- Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight Loss · Phase 2 · Veru Inc.
- A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin · Phase 3 · Eli Lilly and Company
Cardiovascular (4 active studies)
- Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension · Phase 2 · Vanda Pharmaceuticals
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease · Phase 3 · Boehringer Ingelheim
Mental health & behavior (3 active studies)
- Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE. · Phase 2 · LB Pharmaceuticals Inc.
- NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia · Phase 3 · Neurocrine Biosciences
Neurology & pain (3 active studies)
- A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-2) · Phase 3 · Bristol-Myers Squibb
- Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy · Phase 3 · Vertex Pharmaceuticals Incorporated
Vaccines (1 active study)
Common conditions studied in Doral
- Psychosis Associated With Alzheimer's Disease (6 active studies). Recruiting Psychosis Associated With Alzheimer's Disease studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Atopic Dermatitis (3 active studies). Atopic dermatitis studies test IL-13 inhibitors, JAK inhibitors, and next-generation topical therapies for moderate-to-severe eczema.
- Alopecia Areata (2 active studies). Recruiting Alopecia Areata studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Alzheimer Disease (2 active studies). Alzheimer's research investigates anti-amyloid antibodies, tau-targeted therapies, and lifestyle interventions aimed at slowing cognitive decline.
- Anatomic Stage IV Breast Cancer AJCC v8 (2 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Bipolar I Disorder (2 active studies). Recruiting Bipolar I Disorder studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
Leading research sponsors in Doral
- NRG Oncology
- Eli Lilly and Company
- National Cancer Institute (NCI)
- Pfizer
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Local regulations and guidelines
Clinical trials in Florida are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Florida research must also comply with the Florida Information Protection Act (FIPA) and additional oversight from the Florida Department of Health.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Doral. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Doral
Hipa.ai aggregates every recruiting study in Doral from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Doral?
There are approximately 87 recruiting clinical trials in Doral, Florida listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Doral pay participants?
Most recruiting trials in Doral compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Doral?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Doral?
The most common conditions under active study in Doral include Psychosis Associated With Alzheimer's Disease (6), Atopic Dermatitis (3), Alopecia Areata (2), Alzheimer Disease (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Doral?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Doral on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Doral?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Doral?
Recruiting research sites in Doral include UM Sylvester Comprehensive Cancer Center at Doral, St. Jude Clinical Research, Universal Axon Clinical Research, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Doral right now?
The largest active categories in Doral are Cancer & tumors (21), Diabetes & metabolic (8), Cardiovascular (4). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.